CoChat

BASHH UK guidelines for the management of syphilis 2024

Kingston, Margaret, Apea, Vanessa, Evans, Ceri, Fifer, Helen, Foster, Kirsty, Patrick, Patrick, Grant, Alison, Manns, Vicky, Ramsden, Sophie, Sinka, Katy, Sukthankar, Ashish, Sullivan, Ann, Tyler, Stephanie · 2024 · International Journal of STD & AIDS

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index; 53 of the 183 sources its claims cite were checked for support.

Abstract

The 2024 UK guidelines for the management of syphilis are in line with current evidence and practice within the UK. Key updates are detailed at the start of the article. These guidelines are accompanied by the first UK guidelines for the management of syphilis in pregnant people and children, 2024.

Overview

CoChat Summary

TL;DR

The 2024 BASHH UK guidelines update recommendations for diagnosing and managing syphilis in people aged 16 and over in UK specialist sexual health services, with key changes including licensed benzathine penicillin with lidocaine, withdrawal of macrolides due to resistance, ceftriaxone as a penicillin alternative, expanded PCR use, and revised serology, lumbar puncture and treatment-interruption advice. They are accompanied by the first UK guidelines for syphilis in pregnant people and children.

Key findings

  • Macrolides are no longer recommended for syphilis treatment due to antimicrobial resistance (point mutation at A2058G or A2059G in the 23S rRNA gene) and poor placental/blood–brain barrier penetration; benzathine penicillin G remains first-line, with penicillin resistance never reported.
  • Benzathine penicillin diluted with lidocaine is now licensed in the UK and is the recommended preparation; ceftriaxone is an alternative appropriate in most cases where penicillin cannot be used.
  • Routine CSF assessment in patients without symptomatic disease is not recommended (1A); CSF examination is indicated with clinical neurological involvement except ophthalmic or otological syphilis, where it is rarely useful (1C). CSF RPR is 51%–82% sensitive and 82%–100% specific; CSF TPHA titre >1:320 is sensitive and specific for neurosyphilis.
  • Epidemiology cited: England 2019 had 7982 infectious syphilis cases, 5875 (74%) in GBMSM, 43% of whom were living with HIV; by 2019 diagnoses in women rose 135% to 597 and doubled in men to 1016. Approximately one-third of sexual contacts of infectious syphilis develop disease (transmission rates 10%–60%), and 46%–60% of contactable partners of early syphilis cases are infected.
  • Treatment interruption: a single 2.4 MU benzathine penicillin G dose gives treponemicidal levels for 2–4 weeks, so subsequent doses within 14 days of the previous dose do not require restarting; for neurosyphilis, interruption >24 h requires restarting the course (1B).

Methods

  • Guideline development by a writing group following the BASHH Framework for Guideline Development, with an equality impact assessment using the NICE tool, CEG review, 2-month public consultation on the BASHH website, and piloting by target users and the BASHH public panel.
  • Systematic literature review of Medline, Embase and the Cochrane library for English-language publications January 2014–December 2020, using 11 defined search strings covering partner notification, treatment, serology, PCR, point-of-care tests, neurosyphilis diagnosis, typing and whole genome sequencing; previous UK and US guidelines were also reviewed.
  • Recommendations are graded (e.g. 1A–2D) and cover diagnosis, treatment regimens, partner notification, follow-up and auditable outcomes (e.g. 97% standards for RPR titre at treatment, treatment adherence and contact action documentation; 65% for RPR titre at 6 months).

Limitations

  • Stated: robust evidence for optimal management of complications and tertiary syphilis is lacking, so recommendations rest mainly on laboratory considerations, biological plausibility, expert opinion, case studies and clinical experience; there is very little evidence on the recommended duration of sexual abstinence after treatment.
  • Stated: no diagnostic gold standard for neurosyphilis means studies use differing definitions, limiting the strength of the evidence base; evidence for T. pallidum PCR in neurosyphilis is weak (small, heterogeneous studies).
  • Stated: the recommendations may not be appropriate in all clinical situations and decisions must rest on clinician judgement, individual patient circumstances and available resources; the guidelines target people aged 16+ in UK specialist STI care, though principles should be adopted across care levels.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/09564624241280406

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

39 Valid · 15 Not valid · 37 Not checked · 16 Own results and interpretations

60 more claims · 24 with their cited sources checked

Create a free account to see all 107 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 29
  • Probably not a substantial claim. 24

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 124 references

Research works printed but not linked: 26

  1. Schaudinn F, 1905, Arb Kaiserl Gesurndheisamte, 22, 527
  2. Schober PC, 1983, Br J Vener Dis, 59, 217
  3. Anderson J, 1989, Genitourin Med, 65, 239
  4. Centers for Disease Control and Prevention, 2004, Morb Mortal Wkly Rep, 53, 966
  5. Prochazka M, Tracking the syphilis epidemic in England: 2010 to 2019. January 2021
  6. Gjestland T, 1955, Acta Derm Venereol Suppl, 35, 3
  7. Page M, 2020, Sex Transm Infect, 97, 1
  8. Larsen SA, 1985, Advances in sexually transmitted diseases, 157
  9. Izzat NN, 1971, Br J Vener Dis, 47, 162
  10. Idsoe O, 1972, Bull World Health Organ, 47, 1
  11. Polnikorn N, 1980, Br J Vener Dis, 56, 363
  12. Goldmeier D, 1981, Pharmatherapeutica, 3, 14
  13. Goh BT, 1984, Br J Vener Dis, 60, 371
  14. Harshan V, 1982, Indian J Dermatol, 27, 119
  15. Xiao H, 2017, Acta Dermatovenerol Croat, 25, 107
  16. Steele RW, 1984, Am J Med, 77, 50
  17. Katsambas A, 1987, Chemioterapia, 6, 549
  18. Gudjonssen H, 1968, Acta Derm Venereol, 48, 15
  19. Graciansky PD, 1961, Br J Vener Dis, 37, 247
  20. Fathilah J, 2003, Med J Malaysia, 58, 437
  21. Weiner AL, 1951, Ohio Med, 47, 720
  22. Perdrup A, 1960, Acta Derm Venereol, 40, 340
  23. Dai T, 2016, Antimicrob Agents Chemother, 61, e01092
  24. Goldman JN, 1970, Trans Am Acad Ophthalmol Otolaryngol, 74, 509
  25. Morrison RE, 1985, Genitourin Med, 61, 359
  26. Patel IH, 1984, Am J Med, 77, 17

Cited by

See all 51

Metadata

Authors
Kingston, M., Apea, V., Evans, C., Fifer, H., Foster, K., Patrick, P., Grant, A., Manns, V., Ramsden, S., Sinka, K., Sukthankar, A., Sullivan, A., & Tyler, S.
Affiliations
  • Manchester University NHS Foundation Trust (GB)
  • Barts Health NHS Trust (GB)
  • Chelsea and Westminster Hospital NHS Foundation Trust (GB)
  • UK Health Security Agency (GB)
  • Central and North West London NHS Foundation Trust (GB)
  • Guy's and St Thomas' NHS Foundation Trust (GB)
  • Churchill Hospital (GB)
  • Bolton NHS Foundation Trust (GB)
Corresponding author
Kingston, Margaret
Venue
International Journal of STD & AIDS
Published
2024-09-13
Volume
35
Issue
14
Pages
1142-1160
ISSN
  • 0956-4624 (ISSN-L)
  • 1758-1052
OpenAlex
W4402545336
Cited by
51
References
124
Citations by year
2026: 31 · 2025: 19 · 2024: 1
FWCI
14.40
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • International Journal of STD & AIDS (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Syphilis Diagnosis and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
Keywords
syphilis, syphilis management, pregnant people, children, sexually transmitted infections, treatment guidelines
MeSH terms
Anti-Bacterial Agents, Child, Female, United Kingdom, Humans, Pregnancy, Pregnancy Complications, Infectious, Syphilis, Syphilis Serodiagnosis, Treponema pallidum

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BASHH UK guidelines for the management of syphilis 2024. https://app.cochat.ai/papers/10.1177/09564624241280406
The paper
Kingston, M., Apea, V., Evans, C., Fifer, H., Foster, K., Patrick, P., Grant, A., Manns, V., Ramsden, S., Sinka, K., Sukthankar, A., Sullivan, A., & Tyler, S. (2024). BASHH UK guidelines for the management of syphilis 2024. International Journal of STD & AIDS. https://doi.org/10.1177/09564624241280406

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.